REGISTERED
on 12 Sep 2023
Last Applicant/ Owned by
Rue de l'Institut 89
Rixensart
BE
B-1330
Serial Number
97251141 filed on 02th Feb 2022
Registration Number
7160470 registered on 12th Sep 2023
Correspondent Address
Christopher M. Hanes
Filing Basis
No Filing Basis
Disclaimer
NO DATA
PENMENVY
Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related disease Read More
Classification Information
Class [005]
Pharmaceutical Products
Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Vaccines
Mark Details
Serial Number
No 97251141
Mark Type
No Service/Collective Mark
Attorney Docket Number
No 84146602
44D Filed
Yes
44D Current
No
44E filed
No
44E Current
Yes
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 12th Sep 2023 | REGISTERED-PRINCIPAL REGISTER |
| 12th Sep 2023 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 27th Jun 2023 | PUBLISHED FOR OPPOSITION |
| 27th Jun 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 07th Jun 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 24th May 2023 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| 17th May 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 26th Apr 2023 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| 26th Apr 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 26th Apr 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |